Guidelines for the investigation and management of mantle cell lymphoma. Br J Haematol. 2012;159:405Y426. 2. A´ lvarez Pa´ez AM, Nogueiras Alonso JM, Serena Puig A. 18F-FDG-PET/CT in lymphoma: Two decades of experience. Rev Esp Med Nucl Imagen Mol. 2012;31:340Y349...
"Mantle Cell Lymphoma- Pipeline Insight, 2024" report outlays comprehensive insights of present scenario and growth prospects across the indication. A detailed picture of the Mantle Cell Lymphoma pipeline landscape is provided which includes the disease overview and Mantle Cell Lymphoma treatment g...
套细胞淋巴瘤(mantle cell lymphoma,MCL)的预后分层 MCL兼具侵袭性淋巴瘤进展迅速和惰性淋巴瘤不可治愈的双重特点,大多数有很强侵袭性,难以治愈,不同治疗方案的中位生存期约3-5年。近年来的临床研究显示,套细胞淋巴瘤也是一组异质性肿瘤,预后差异很大...
Mantle cell lymphoma doi:10.1007/s11864-000-0041-xCurrent Treatment Options in OncologyDensmore, J JWilliams, M E
Mantle cell lymphoma represents a specific subtype of B -cell non-Hodgkin lymphoma characterized on the molecular level by translocation t(11;14)(q13;q32) leading to aberrant overexpression of cyclin D1 and deregulation of the cell cycle. Despite sporadic indolent forms of mantle cell lymphoma...
Novel therapies under investigation for mantle cell lymphoma: Expert Opinion on Investigational Drugs: Vol 25, No 4 Clinical practice guidelines for diagnosis, treatment, and follow-up of patients with mantle cell lymphoma. Recommendations from the GEL/TAMO Spanish ... T Robak - 《Expert Opinion ...
Mantle cell lymphoma (MCL) predominantly affects older adults, with a median age at diagnosis of 70 years. A frequently aggressive yet incurable lymphoma, the goal of therapy for MCL is to turn a potentially life-threatening illness into a chronic disease with prolonged periods of remission. Larg...
Dr. Geisler explained that mantle-cell lymphoma is a rare subtype of lymph cancer, representing about 10% of all lymphoma, and has one of the worst prognoses, with half of patients dying within 3 to 4 years of the diagnosis, even after treatment with anthracyclines. "Until now, it has be...
Mantle-cell lymphoma (MCL) is a lymphoproliferative disorder derived from a subset of naive pregerminal center cells characterized by a nodular or diffuse proliferation of atypical lymphoid cells with a monoclonal B-cell phenotype and coexpression of CD5. Two cytologic variants have been identified,...
[Therapy of mantle cell lymphoma] Schmidt C and Dreyling M: Therapy of mantle cell lymphoma: Current standards and future strategies. Hematol Oncol Clin North Am 22: 953‑963, ... M Dreyling,M Unterhalt,O Weigert,... - 《Der Internist》 被引量: 16发表: 2007年 Current treatment stand...